← Open Payments lookup

DANIEL HA: Open Payments

NPI 1023503984 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$820 in 44 payments from 11 companies in 2025. Trend: 2023 $362 · 2024 $518 · 2025 $820

Food & beverage: $802Education: $18
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.14$182
Alkermes, Inc.8$163
Vanda Pharmaceuticals Inc.4$105
Otsuka America Pharmaceutical, Inc.4$92
ABBVIE INC.4$85
Supernus Pharmaceuticals, Inc.3$44
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$39
Teva Pharmaceuticals USA, Inc.2$35
Axsome Therapeutics, Inc.1$30
Noven Therapeutics, LLC1$24

Products named: TRINTELLIX, ARISTADA, FANAPT, VRAYLAR, REXULTI, LYBALVI, Qelbree, CAPLYTA.

Industry payments across TX — which companies pay providers there.